APPLICATION
ANDA204234
TYPE
ANDA
ORIGINAL APPROVAL
2014-03-05
LATEST ACTION
2026-06-12
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 75MG BASE · CAPSULE · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 100MG BASE · CAPSULE · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 50MG BASE · CAPSULE · ORAL
Approval history
2026-06-12Labeling · Supplement 11 · standardAP
2025-04-25Labeling · Supplement 6 · standardAP
2025-04-25Labeling · Supplement 10 · standardAP
2017-09-19Labeling · Supplement 2 · standardAP
2016-10-18Labeling · Supplement 1 · standardAP
2014-03-05UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.